9 results ยท Page 1 of 1

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
A Study to Evaluate the Impact of Pre-procedural Intracoronary Nicorandil Injection to PREVENT reductioN Of decREased TIMI FLOW in Patients Who Undergoing Percutaneous Coronary Intervention for the Coronary Artery DiseaseArterial Occlusive Diseases, No-Reflow Phenomenon, Pathologic Processes, Pathological Conditions, Signs and Symptoms, arteriosclerosis disorder, cardiovascular disorder, coronary artery disorder, heart disorder, ischemic disease, myocardial ischemia, vascular disorderRecruitingPhase 42026-09-08NCT05427786
Insulin Resistance and Its Association With no Reflow Phenomenon After Primary PCI in Type II Diabetic STEMI Patients.Infarction, Necrosis, No-Reflow Phenomenon, Pathologic Processes, Pathological Conditions, Signs and Symptoms, ST-elevation myocardial infarction, cardiovascular disorder, heart disorder, ischemic disease, myocardial infarction, myocardial ischemia, vascular disorderNot yet recruitingNot stated2026-07-16NCT07706335
Adenosine Pre-Medication in Primary Percutaneous Coronary InterventionInfarction, Necrosis, No-Reflow Phenomenon, Pathologic Processes, Pathological Conditions, Signs and Symptoms, ST-elevation myocardial infarction, acute myocardial infarction, cardiovascular disorder, heart disorder, ischemic disease, myocardial infarction, myocardial ischemia, vascular disorderRecruitingPhase 42026-04-22NCT07536802
Investigation of Brain Blood Flow Changes in Acute Ischemic Stroke Patients After Successful Endovascular ThrombectomyNo-Reflow Phenomenon, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Stroke, Acute, brain disorder, cardiovascular disorder, central nervous system disorder, cerebrovascular disorder, ischemic disease, ischemic stroke, nervous system disorder, stroke disorder, vascular disorderRecruitingNot stated2026-04-16NCT07534319
Empagliflozin for No-reflow Phenomenon in PCI for STEMIInfarction, Necrosis, No-Reflow Phenomenon, Pathologic Processes, Pathological Conditions, Signs and Symptoms, ST-elevation myocardial infarction, cardiovascular disorder, heart disorder, ischemic disease, myocardial infarction, myocardial ischemia, vascular disorderActive, not recruitingPhase 22026-04-15NCT06342141
Rivaroxaban for Slow Coronary Flow After PCI in STEMIInfarction, Necrosis, No-Reflow Phenomenon, Pathologic Processes, Pathological Conditions, Signs and Symptoms, ST-elevation myocardial infarction, cardiovascular disorder, heart disorder, ischemic disease, myocardial infarction, myocardial ischemia, vascular disorderNot yet recruitingPhase 42025-09-29NCT07195812
Validation of New Biomarkers for Predicting No-Reflow in STEMI Patients Undergoing Primary PCIInfarction, Necrosis, No-Reflow Phenomenon, Pathologic Processes, Pathological Conditions, Signs and Symptoms, cardiovascular disorder, heart disorder, ischemic disease, myocardial infarction, myocardial ischemia, vascular disorderNot yet recruitingNot stated2025-08-29NCT07132489
The Investigator Administers Intracoronary Adrenaline Via the Catheter in STEMI Patients During Primary PCI, After Flow Restoration and Before Stenting, and Studies Its Effect in Prevention of No ReflowInfarction, Necrosis, No-Reflow Phenomenon, Pathologic Processes, Pathological Conditions, Signs and Symptoms, ST-elevation myocardial infarction, cardiovascular disorder, heart disorder, ischemic disease, myocardial infarction, myocardial ischemia, vascular disorderRecruitingPhase 32025-03-11NCT06847568
Upfront Premedication For Reduction of Microvascular Obstruction and No-reflow in Treating ST-segment Elevation Myocardial InfarctionInfarction, Necrosis, No-Reflow Phenomenon, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Postoperative Complications, ST-elevation myocardial infarction, cardiovascular disorder, heart disorder, ischemia reperfusion injury, ischemic disease, myocardial infarction, myocardial ischemia, vascular disorderNot yet recruitingNot applicable2023-08-31NCT05393557